Institutional investors purchased a net $2.3 million shares of DEPO during the quarter ended June 2016 and now own 106.98% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SIMPLEX TRADING LLC Bought 55.3 Thousand shares of Depomed Inc
LEGAL & GENERAL INVESTMENT MANAG... Bought 43.2 Thousand shares of Depomed Inc